abstract |
Disclosed herein are heterocyclic compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structure of formula (I) Wherein R 1 , R 2 , and X are as defined in the detailed description. Methods of inhibiting ITK activity in human or animal subjects are also presented. |